Table 4.

Assessments

Elksniņš-Finogejevs et al.23	VAS, IKDC, and KSS scales at 1 week, 5 weeks, 15 weeks, 30 weeks, and 1 year after treatment
Forogh et al.17	KOOS, the 20 MW test, ROM, flexion contracture, and VAS were assessed before, 2 months, and 6 months after interventions
Uslu Güvendi et al.18	VNS, WOMAC, Lequesne index, and the HAD Scale pretreatment, and at 2 and 6 months posttreatment
Huang et al.24	WOMAC score prior to the first injection and then at 3, 6, 9, and 12 months; VAS pain prior to treatment and after 12 months
Jubert et al.19	VAS at 1 month, KOOS and SF-36 at 1, 3, and 6 months after treatment
Naderi Nabi et al.20	VAS and KOOS monthly for 3 consecutive months, as well as 6 months after the treatment
Freire et al.21	KSS and WOMAC preinjection and after 1 month and 6 months of intervention
Khan et al.25	WOMAC every 2 weeks for 6 months
Nunes-Tamashiro et al.22	Patients were assessed at baseline and after 4, 8, 12, and 52 weeks with VAS, WOMAC, Timed to Up and Go test, 6-min walk test, percentage of improvement, goniometry, quality of life SF-36 questionnaire, Likert scale and K–L radiographic scale (only at baseline and 52 weeks)

20 MW test, 20 meters walk test; HAD Scale, Hospital Anxiety and Depression Scale; IKDC, International Knee Documentation Committee; KOOS, Knee Injury and Osteoarthritis Outcome Scale; KSS, Knee Society Score; K–L, Kellgren–Lawrence; ROM, range of motion; SF-36, Short Form-36; VAS, Visual Analog Scale; VNS, Visual Numeric Scale; WOMAC, Western Ontario and McMaster Universities Arthritis Osteoarthritis Index.